3 China-Exposing ETFs Launched this Week – And One New Cancer Research ETF You May Not Want to Miss
October 23, 2015 at 10:17 AM EDT
Two currency-hedged ETFs that track China A-Shares and one smart beta ETF were launched this week on Tuesday, October 20. Below is a look at what these ETFs mean for you, and how you can more easily get exposure to China into your portfolio. The other exciting ETF launch last week is the Loncar Cancer Immunotherapy ETF ( CNCR ), which offers exposure to the pharmaceutical industry with a focus on cancer research firms.
